These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27437880)

  • 21. Cardiovascular, orthopedic, and physical medicine diagnostic devices; reclassification of cardiopulmonary bypass accessory equipment, goniometer device, and electrode cable devices. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(70):19317-9. PubMed ID: 11010630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical Device; exemption from premarket notification; class II devices; pharmacy compounding systems. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Mar; 66(55):15796-8. PubMed ID: 11706859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical devices; exemptions from premarket notification; class II devices. Final rule.
    Food and drug Administration, HHS
    Fed Regist; 2001 Nov; 66(221):57368-9. PubMed ID: 11776279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical devices; reclassification of three anesthesiology preamendments class III devices into class II. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(221):57366-8. PubMed ID: 11776278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obstetric and gynecology devices; effective date of requirement for premarket approval for glans sheath devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(115):40848-9. PubMed ID: 12068899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiological Medical Device Innovation: Approvals via the Premarket Approval Pathway From 2000 to 2015.
    Ghobadi CW; Hayman EL; Finkle JH; Walter JR; Xu S
    J Am Coll Radiol; 2017 Jan; 14(1):24-33. PubMed ID: 28061962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical medicine devices; reclassification of stair-climbing wheelchairs. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Apr; 79(71):20779-83. PubMed ID: 24741753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orthopedic devices; reclassification of the intervertebral body fusion device. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jun; 72(112):32170-2. PubMed ID: 17632942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical devices; effective date of requirement for premarket approval for three preamendment class III devices. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(72):19833-4. PubMed ID: 11010634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices.
    Dhruva SS; Bero LA; Redberg RF
    JAMA; 2009 Dec; 302(24):2679-85. PubMed ID: 20040556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premarket clinical evaluation of novel cardiovascular devices: quality analysis of premarket clinical studies submitted to the Food and Drug Administration 2000-2007.
    Kramer DB; Mallis E; Zuckerman BD; Zimmerman BA; Maisel WH
    Am J Ther; 2010; 17(1):2-7. PubMed ID: 20038828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution of substantial equivalence in FDA's premarket review of medical devices.
    Goldberger BA
    Food Drug Law J; 2001; 56(3):317-37. PubMed ID: 11944642
    [No Abstract]   [Full Text] [Related]  

  • 34. Effective date of requirement for premarket approval for three class III preamendments devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Aug; 76(158):50663-7. PubMed ID: 21845785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategic planning for U.S. premarket approval submissions.
    Donawa M
    Med Device Technol; 2006 Sep; 17(7):21-3. PubMed ID: 17039953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Priority vs Standard US Food and Drug Administration Premarket Approval Review for High-Risk Medical Devices.
    Ong C; Ly VK; Redberg RF
    JAMA Intern Med; 2020 May; 180(5):801-803. PubMed ID: 32227126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New FDA draft guidance on premarket submissions.
    Donawa ME
    Med Device Technol; 1999 Oct; 10(8):12-4. PubMed ID: 10724773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
    Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
    Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDA marketing claims, and the practitioner.
    Runner S
    J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular devices; classification of electrocardiograph electrodes. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Jul; 76(140):43582-5. PubMed ID: 21780327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.